Italy -
Italian -
AIFA (Agenzia Italiana del Farmaco)
uft 36cps 100mg 224mg
merck serono spa - tegafur/uracile - capsule - "capsule rigide" 36 capsule in blister pvc/pvdc/al
Italy -
Italian -
AIFA (Agenzia Italiana del Farmaco)
uft
merck serono s.p.a. - tegafur, associazioni - tegafur, associazioni
European Union -
Italian -
EMA (European Medicines Agency)
teysuno
nordic group b.v. - tegafur, gimeracil, oteracil - neoplasie dello stomaco - agenti antineoplastici - teysuno is indicated in adults:- for the treatment of advanced gastric cancer when given in combination with cisplatin (see section 5. - as monotherapy or in combination with oxaliplatin or irinotecan, with or without bevacizumab, for the treatment of patients with metastatic colorectal cancer for whom it is not possible to continue treatment with another fluoropyrimidine due to hand-foot syndrome or cardiovascular toxicity that developed in the adjuvant or metastatic setting.